Dyslipidemia and Insulin Resistance in Relation to Genetic Admixture among Hispanics and Non-Hispanic Blacks of Caribbean Origin

Journal of the National Medical Association

Volumn 96, Issue 3, 2004, Pages 332-340

  Tull, Eugene S ^a,c   Thurland, Ann ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b Div of Hlth Educ and Prevention   (Virgin Islands (U.S.))

^c 512 Paran Hall ^*  (United States)

Author keywords

Dyslipidemia; Insulin resistance

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; TRIACYLGLYCEROL;

ADULT; AFRICAN CARIBBEAN; ANTHROPOMETRIC PARAMETERS; ARTICLE; CARDIOVASCULAR DISEASE; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GENETIC ADMIXTURE; GENETIC RISK; GLUCOSE BLOOD LEVEL; HEREDITY; HISPANIC; HUMAN; HUMAN EXPERIMENT; HUMAN GENETICS; HYBRID; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; POPULATION GENETICS; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; VIRGIN ISLANDS (U.S.);

AFRICAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; HYPERLIPIDEMIAS; INSULIN RESISTANCE; LIFE STYLE; MALE; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES; WEST INDIES;

EID: 1442307048     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Haffner SM, D'Agostin R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes. 1996;45:742-748.
2. Chui KC, Chuang LM, Yoon C. Comparison of measured and estimated indices of insulin sensitivity and β-cell function: impact of ethnicity on insulin sensitivity and β-cell function in glucose-tolerant and normotensive subjects. J Clin Endocrinol Metab. 2001;86:1620-1625.
3. Batey LS, Goff Jr DC, Tortolero SR, et al. Summary measures of the insulin resistance syndrome are adverse among Mexican-American versus non-Hispanic white children: the Corpus Christi Child Heart Study. Circulation. 1997;96:4319-4325.
4. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the U.S. population from the Third National Health and Nutrition Examination Survey, 1998-1994. Arch Intern Med. 2003;163:427-436.
5. Haffner SM, D'Agostino R, Goff D, et al. LDL Size in African Americans, Hispanics, and Non-Hispanic Whites. Arterioscler Thromb Vas Biol. 1999;19:2234-2240.
6. Sorlie PD, Sharrett AR, Patsch W, et al. The relationship between lipids/lipoproteins and atherosclerosis in African Americans and Whites: The Atherosclerosis Risk in Communities Study. Ann Epidemiol. 1999;9:149-158.
7. U.K. Prospective Diabetes Study Group. U.K. Prospective Diabetes Study. XII: Differences among Asian, Afro-Caribbean and white caucasian type-2 diabetic patients at diagnosis of diabetes. Diabet Med. 1994;11:670-677.
8. Chaturvedi N, Mckeigue PM, Marmot MG. Relationship of glucose intolerance to coronary risk in Afro Caribbeans compared to Europeans. Diabetologia. 1994;38:630-631.
9. Parra EJ, Marcini A, Akey J, et al. Estimating African-American admixture proportions by use of population specific alleles. Am J Hum Genet. 1998;63:1839-1851.
10. Hannis CL, Hewett-Emmett D, Bertin TK, et al. Origins of U.S. Hispanics. Implications for diabetes. Diabetes Care. 1991; 14:618-627.
11. Tull ES, LaPorte RE, Kriska A, et al. Glucose intolerance by race and ethnicity in the U.S. Virgin Islands. J Natl Med Assoc. 2002;9:135-142.
12. Lohman TG, Roche AF, Martorell R, eds. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics, 1988.
13. Bucolo G, David H. Quantitative determination of serum triglycerides by use of enzymes. Clin Chem. 1973;19:476-482.
14. Warnick GR, Albert JJ. A comprehensive evaluation of heparin-manganese precipitation procedure for estimating high lipoprotein cholesterol. J Lipid Res. 1978;19:65-76.
15. The Expert Panel. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285: 2486-2499.
16. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985;28:412-419.
17. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442-443.
18. Tull ES, Roseman JM, Christian CL. Epidemiology of childhood IDDM in the U.S. Virgin Islands from 1979 to 1988. Evidence of an epidemic in the early 1980s and variation by degree of racial admixture. Diabetes Care. 1991;14:558-564.
19. Mitchel BD, Williams-Blangero S, Chakraborty R, et al. A comparison of three methods for assessing Amerindian admixture in Mexican Americans. Ethn Dis. 1993;3:22-31.
20. SAS Institute. SAS Procedures Guide Version 6, 3rd Ed., Cary, NC, SAS Inst., 1990.
21. Vermaak WJ, Ubbink JB, Delport R, et al. Ethnic immunity to coronary heart disease? Atherosclerosis. 1991;89:155-162.
22. Zoratti R, Godsland IF, Chaturvedi N, et al. Relation of plasma lipids to insulin resistance, nonesterified fatty acid levels, and body fat in men from three ethnic groups: relevance to variation in risk of diabetes and coronary disease. Metabolism. 2000;49:245-252.
23. Vega GL, Clark LT, Tang A, et al. Hepatic lipase activity is lower in African-American men than in white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res. 1998;39:228-232.
24. Desai PP, Bunker CH, Ukoli FAM, et al. Genetic variation in the apolipoprotein D gene among African blacks and its significance in lipid metabolism. Atherosclerosis. 163:329-338.
25. Saad MF, Lillioja S, Nyomba BL, et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med. 1991;324:733-739.
26. Williams RC, Long JC, Hanson RL, et al. Individual estimates of European genetic admixture associated with lower body-mass index, plasma glucose, and prevalence of type-2 diabetes in Pima Indians. Am J Hum Genet. 2000;66:527-538.
27. Chakraborty R, Ferrell RE, Stern MP, et al. Relationship of prevalence of noninsulin-dependent diabetes mellitus to Amerindian admixture in the Mexican Americans of San Antonio, Texas. Genet Epidemiol. 1986;3:435-454.
28. Garza-Chapa R, De Los Angeles Rojas-Alvarado M, Cerda-Flores RM. Prevalence of NIDDM in Mexicans with paraphyletic and polyphyletic surnames. Am J Human Biol. 2000;12:721-728.
29. Fontbonne A, Papoz L, Eschwege E, et al. Features of insulin-resistance syndrome in men from French Caribbean islands. The Telecom Study. Diabetes. 1992;41:1385-1389.
30. Howard BV, Mayer-Davis EJ, Goff D, et al. Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin-Resistance Atherosclerosis Study. Metabolism. 1998;47:1174-1179.
31. Griffin FR. Cardiovascular disease in the United States: an epidemiological overview. Cardiovasc Clin. 1991;21:3-16.
32. Jones DW, Chambless LE, Folsom AR, et al. Risk factors for coronary heart disease in African Americans: the atherosclerosis risk in communities study, 1987-1997. Arch Intern Med. 2002;162:2565-2571.
33. Wild S, Mckeigue P. Cross-sectional analysis of mortality by country of birth in England and Wales, 1970-1992. Br Med J. 1997;14:705-710.
34. U.K. Prospective Diabetes Study Group. The incidence of myocardial infarction in white, South Asian, and Afro-Caribbean patients with type-2 diabetes (U.K. Prospective Diabetes Study 32). Diabetes Care. 1998;21:1271-1277.
35. Sundquist J, Winkleby MA, Pudaric S. Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: an analysis of NHANES III, 1988-1994. Third National Health and Nutrition Examination Survey. J Am Geriartr Soc. 2001;49:109-116.
36. Reaven G, Segal K, Hauptman J, et al. Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X. Am J Cardiol. 2001;87:827-831.
37. Reaven GM. Importance of identifying the overweight patient who will benefit most by losing weight. Ann Intern Med. 2003;138:420-423.